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ABSRACT 
Objectives: Fatigue remains a debilitating feature of systemic lupus erythematosus (SLE). 
Although in some cases this may be the result of intercurrent fibromyalgia, mood disorder or 
untreated metabolic syndrome, in many cases the cause is unclear. The aim of this study was 
to investigate the relationship between fatigue and red cell distribution width (RDW), a 
measure of variability in erythrocyte size and volume.  
Method: A total of 225 patients were recruited from three clinics in England and Australia. 
Patients completed the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue 
Score or 12-item Short Form survey (SF-12) to measure fatigue, which was compared with 
RDW and haemoglobin. In a subgroup of 72 patients, markers of disease activity were also 
assessed for correlation with fatigue using univariate and multivariate analysis with fatigue as 
the dependent variable. 
Results: In all three groups, significant correlations between fatigue and RDW were observed 
(p<0.001; p=0.02; p<0.001 respectively) and this was preserved in multivariate analysis. There 
was no correlation between fatigue and haemoglobin in two groups (with the correlation 
between RDW and fatigue remaining significant in non-anaemic patients in the third group). 
In subgroup analysis, fatigue was not associated with any measures of disease activity.  
Conclusions: We report a reproducible, statistically significant association between RDW and 
fatigue levels in a diverse population of patients with SLE. The findings of this study raise the 
possibility of a potential novel biological basis for fatigue in those in whom there is a lack of 
an alternate explanation. 
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INTRODUCTION 
 
The majority of patients with systemic lupus erythematosus (SLE) report fatigue with 80-90% 
describing this as the single most debilitating symptom[1, 2]. Previous studies have found no 
apparent correlation between fatigue and disease activity[3]. The cause of fatigue in SLE is 
poorly understood and poses significant challenges for both patient and clinician. 
Fibromyalgia[4], depression[5] and metabolic disorders (such as hypothyroidism)[6] can all 
lead to fatigue and are commonly seen in SLE. However, in a large number of cases the cause 
is unexplained, thus representing a significant area of unmet need. 
 
Red cell distribution width (RDW), a measure of variation in erythrocyte size and volume, has 
been found to be higher in patients with SLE than healthy controls[7] and shown to correlate 
with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and SLE Disease Activity 
Index 2000 (SLEDAI-2K)[8]. Furthermore, elevated RDW at diagnosis of SLE has been 
reported to predict poorer clinical outcomes[9]. In this study, we aimed to investigate whether 
there is an association between RDW and fatigue in patients with SLE for the first time.  
 
METHODS 
 
Patient recruitment 
 
Three groups of patients were recruited from specialist Lupus Clinics in London (United 
Kingdom) and Sydney (Australia). All eligible participants fulfilled American College of 
Rheumatology (ACR) criteria and provided informed consent. 
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Group 1 (test group) 
 
Patients with juvenile-onset lupus (diagnosed before the age of 16) were recruited from the 
Young Adult Lupus Clinic at University College London Hospital (UCLH), UK. Fatigue was 
measured using the validated Functional Assessment of Chronic Illness Therapy (FACIT) 
Fatigue score v4. This 13-domain questionnaire generates a numerical score (0-52), where a 
lower score represents more fatigue. Haemoglobin (Hb), RDW and markers of disease activity 
including ESR, Complement C3 (C3), double-stranded DNA binding (dsDNA), CRP and 
SLEDAI-2K were recorded at the same visit. Anaemia was defined as per World Health 
Organisation (WHO) guidance (Hb <120 g/L in women and <130 g/L in men).  
 
Group 2 (validation group) 
 
Patients with adult-onset SLE were recruited from the UCLH Adult Lupus Clinic and 
completed the 12-item Short Form survey v2 (SF-12). This validated quality of life 
questionnaire consists of 12 items across 8 domains including one specifically relating to 
vitality. Responses are transformed to a numerical scale (0-100) with a lower vitality score 
indicative of higher levels of fatigue. As with Group 1, Hb and RDW were collected. 
 
Group 3 (second validation group) 
 
Patients with adult-onset lupus were prospectively recruited from the Lupus Clinic at Liverpool 
Hospital, Sydney (Australia). Fatigue was measured using the FACIT Fatigue score (as in 
Group 1) and Hb and RDW were recorded. 
 
 5 
Statistical analysis 
 
Spearman’s rank or Pearson’s correlation were used to determine significance between 
independent variables. T-test or Mann Whitney test were used for comparisons between two 
groups.  In Group 1, multivariate linear regression analysis was conducted with FACIT Fatigue 
score as the dependent variable. RDW and markers of disease activity (dsDNA, C3, ESR, CRP 
and SLEDAI-2K) were independent variables. 
 
RESULTS 
 
Patient demographics 
 
A total of 225 patients were recruited across the three groups. Demographic details are 
summarised in Table 1. The defined upper limit of the normal range for RDW in the UK based 
groups was higher (11.5-14.5%) than those used in the Australian group (11.6-14.0%). A 
statistically significant difference was seen in RDW between the two UK based groups and the 
Australian group, likely to be representative of this inter-laboratory variation. 
 
Variables associated with fatigue in Group 1 
 
As shown in Figure 1a, FACIT Fatigue score correlated negatively with RDW (p<0.001; r= -
0.44). A correlation between FACIT and Hb was also noted, although to a lesser degree 
(p=0.01; r= -0.30). Therefore, to assess if the correlation between RDW and FACIT remained 
independent of anaemia status, those who were anaemic were excluded (n=21). The correlation 
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between FACIT and RDW remained significant in non-anaemic patients (n=51; p=0.001; r= -
0.44).  
 
FACIT Fatigue score did not correlate with C3 (p=0.17), dsDNA binding (p=0.40), CRP 
(p=0.10) or SLEDAI-2K (p=0.60) by univariate analysis. A borderline correlation was seen 
with ESR (p=0.05; r= -0.23). After adjusting for disease activity in multivariate analysis, only 
RDW (p=0.02) and ESR (p=0.03) were independently associated with FACIT Fatigue score. 
 
Validation groups 
 
Figure 1b shows that in Group 2 Vitality scores also correlated negatively with RDW (p=0.02; 
r= -0.23) although there was no statistically significant association with Hb (p=0.25). In Group 
3, FACIT Fatigue score again correlated with RDW (p=0.03; r= -0.32), as shown in Figure 1c. 
There was no correlation between FACIT Fatigue score and Hb (p=0.87). 
 
DISCUSSION 
 
In this study, we demonstrate for the first time, a significant correlation between fatigue and a 
biological marker in SLE. Our results demonstrate an association between elevated RDW and 
higher levels of fatigue in three groups of patients of varying age, ethnicity and disease duration 
in two countries. The results have been validated using two different fatigue scores. Our 
findings support previous evidence suggesting fatigue does not typically correlate with disease 
activity[3, 10]. 
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An elevated RDW is commonly an early marker of iron deficiency[11], which is a well-
described cause of fatigue, ultimately as a result of anaemia. However, our findings suggest 
that the correlation between fatigue and RDW is independent of Hb. Another possible 
explanation is Functional Iron Deficiency (FID), of which RDW has been suggested as a 
surrogate marker[12]. Compared with absolute iron deficiency, FID occurs in the context of 
normal iron concentrations, although iron cannot be mobilised or released from stores at an 
adequate rate to meet physiological demands. There is a growing evidence to support the role 
of FID in the pathogenesis of fatigue in a number of chronic conditions including malignancy, 
Parkinson’s disease and cardiac failure.[13-15]. 
 
There are some limitations in this study. We appreciate fatigue is a heterogeneous symptom 
and contributory factors may include intercurrent mood disorders, fibromyalgia and sleep 
disturbance. 
 
In conclusion, we report the novel findings of a large-scale study of a diverse group of patients 
with SLE that provides evidence supporting a possible biological basis for the pathogenesis of 
fatigue in a subgroup of patients.  
 
ACKNOWLEDGEMENTS 
 
Acknowledgements We are grateful to all patients who participated in this study. Thanks to 
Dr Thomas McDonnell for critical reading and editing of the manuscript. 
 
 8 
Funding CW is supported by grants from Versus Arthritis [549143] and LUPUS UK [176255]. 
This work was carried out at a unit supported by the National Institute for Health Research 
University College London Hospitals Biomedical Research Centre 
 
Ethics approval Fatigue data and samples from all patients were obtained with informed 
consent and after approval from local ethics committees in the UK (Ref 11/LO/0330 and Ref 
11/WM/0033) and from the Research and Ethics Office, South Western Sydney Local Health 
District (Ethics Number SWSLHD HREC 10/23 Inflammatory Targets of SLE) in Australia. 
This study complies with the declaration of Helsinki. 
 
Contributors CW, AR and TR were all involved in the conception and design of the study. 
CW collected all data relating to Group 1. SC and CP were involved in acquisition of data 
relating to Group 2. MN, KB and SO acquired data relating to Group 3. BT provided support 
with analysis and data interpretation. CW was responsible for drafting the manuscript and this 
was revised by all authors. All authors approved the final version to be published. 
 
CONFLICTS OF INTEREST 
 
None declared 
 
REFERENCES 
 
1. TENCH CM, MCCURDIE I, WHITE PD, et al.: The prevalence and associations of 
fatigue in systemic lupus erythematosus. Rheumatology 2000;39(11):1249-54. 
 9 
2. FONSECA R, BERNARDES M, TERROSO G, et al.: Silent Burdens in Disease: 
Fatigue and Depression in SLE. Autoimmune Dis 2014;790724. doi: 
10.1155/2014/790724 
3. OMDAL R, MELLGREN SI, KOLDINGSNES W, et al.: Fatigue in patients with 
systemic lupus erythematosus: lack of associations to serum cytokines, 
antiphospholipid antibodies, or other disease characteristics. J Rheumatol 
2002;29(3):482-6. 
4. GILES I, ISENBERG DA.: Fatigue in primary Sjogren’s syndrome: is there a link with 
the fibromyalgia syndrome? Ann Rheum Disease 2000;59(11):875-878 
5. ARNAUD L, GAVAND PE, VOLL R, et al.: Predictors of fatigue and severe fatigue 
in a large international cohort of patients with systemic lupus erythematosus and a 
systematic review of the literature. Rheumatology 2018;[epub ahead of print] doi: 
10.1093/rheumatology/key398 
6. LUO W, MAO P, ZHANG L, YANG Z.: Association between systemic lupus 
erythematosus and thyroid dysfunction: a meta-analysis. Lupus 2018;27(13):2120-
2128. doi: 10.1177/0961203318805849 
7.  VAYA A, ALIS R, HERNANDEZ JL, et al.: RDW in patients with systemic lupus 
erythematosus. Influence of anaemia and inflammatory markers. Clin Hemorheol 
Microcirc 2013;54(3):333-9. 
8. HU ZD, CHEN Y, ZHANG L, et al.: Red blood cell distribution width is a potential 
index to assess the disease activity of systemic lupus erythematosus. Clin Chim Acta 
2013;425:202-5. 
9. ZOU XL, LIN XJ, NI X, et al.: Baseline Red Blood Cell Distribution Width Correlates 
with Disease Activity and Therapeutic Outcomes in Patients with Systemic Lupus 
Erythematosus, Irrespective of Anemia Status. Clin Lab 2016;62(10):1841-1850. 
 10 
10. AZIZODDIN DR, GANDHI N, WEINBERG S, et al.: Fatigue in systemic lupus 
erythematosis: the role of disease activity and its correlates. Lupus 2018;[epub ahead 
of print] doi: 10.1177/0961203318817826 
11. BADRICK T, RICHARDSON AM, ARNOTT A, et al.: The early detection of anaemia 
and aetiology prediction through the modelling of red cell distribution width (RDW) in 
cross-sectional community patient data. Diagnosis (Berl) 2015;2(3):171-179. doi: 
10.1515/dx-2015-0010 
12. CHIARI MM, BAGNOLI R, DE LUCA PD, et al.: Influence of acute inflammation on 
iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 1995;43(7):767-
771. 
13. GRELLIER N, DERAY G, YOUSFI A, et al.: Functional iron deficiency, inflammation 
and fatigue after radiotherapy. Bull Cancer 2015;102(9):780-5. 
14. COMIN-COLET J, ENJUANES C, GONZALEZ G, et al. Iron deficiency is a key 
determinant of health-related quality of life in patients with chronic heart failure 
regardless of anaemia status. Eur J Heart Fail 2013;15(10):1164-72. 
15. ZUO LJ, YU SY, HU Y, et al. Serotonergic dysfunctions and abnormal iron 
metabolism: Relevant to mental fatigue of Parkinson disease. Sci Rep 2016;6(1):19. 
 
 
 
 
 
 
 
 
 11 
 
 
 
 
 
 
FIGURES AND TABLES 
 
TABLE 1 
 
Characteristic Group 1 Group 2 Group 3 p Value 
Number of patients 72 106 47  
Mean age [Years] (SD) 21.3 (4.4) 43.7 (14.1) 46.4 (15.9) <0.001a 
Female (%) 65 (90%) 101 (95%) 44 (94%) 0.42 
Ethnicity (%) 
Caucasian 
Afro-Caribbean 
South Asian 
East Asian 
Other 
 
23 (32%) 
18 (25%) 
22 (31%) 
4 (6%) 
5 (6%) 
 
61 (58%) 
29 (27%) 
10 (9%) 
0 
6 (6%) 
 
17 (36%) 
0 
5 (11%) 
19 (40%) 
6 (13%) 
 
Mean Hb [g/L] (SD) 
Range 
128.7 (16.8) 
76-171 
123.9 (16.5) 
74-155 
126.4 (14.8) 
96-156 
0.28 
Mean RDW [%] (SD) 
Range 
14.2 (1.9) 
12.0-22.0 
14.2 (1.7) 
11.9-21.1 
13.3 (1.7) 
10.7-18.8 
0.001b 
Fatigue Score 
Mean FACIT score (SD) 
Mean Vitality score (SD) 
 
33.4 (14.8) 
 
 
 
45.5 (10.3) 
 
29.9 (12.7) 
 
 
0.13 
Mean disease duration [years] (SD) 8.0 (4.7) 15.5 (9.7) 9.9 (6.6) <0.001c 
a Significant difference between Cohort 1 and Cohorts 2, 3 
b Significant difference between Cohort 3 and Cohorts 1, 2 
c Significant difference between Cohort 1 and Cohort 2; and between Cohort 2 and Cohort 3 
 
 
FIGURE 1 
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FIGURE LEGENDS 
 
TABLE 1: 
Demographic and clinical characteristics of the three study groups (n=225). 
 
FIGURE 1: 
A statistically significant correlation was observed between RDW and levels of fatigue in 
all three groups of patients with SLE. For both FACIT and Vitality domain of SF-36 lower 
scores imply worse fatigue; thus negative correlation between RDW and FACIT or Vitality 
score means that high RDW is associated with more fatigue. 
a) Group 1 – patients with juvenile-onset SLE from UCLH, London (n=72) showed a negative 
correlation between RDW and FACIT Fatigue score; b) Group 2 – patients with adult-onset 
SLE recruited from UCLH, London (n=106) showed a negative correlation between RDW and 
Vitality domain of SF-12; and c) Group3 – patients with SLE adult-onset lupus from Liverpool 
Hospital, Sydney (n=47) showed a negative correlation between RDW and FACIT Fatigue 
score. 
